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Translational neurophysiology in sheep:
measuring sleep and neurological dysfunction
in CLN5 Batten disease affected sheep
Nicholas Perentos,1 Amadeu Q. Martins,1 Thomas C. Watson,1,* Ullrich Bartsch,2
Nadia L. Mitchell,3 David N. Palmer,3 Matthew W. Jones2 and A. Jennifer Morton1
Creating valid mouse models of slowly progressing human neurological diseases is challenging, not least because the short lifespan of
rodents confounds realistic modelling of disease time course.With their large brains and long lives, sheep offer signiﬁcant advantages for
translational studies of humandisease.Hereweusednormal andCLN5Batten disease affected sheep to demonstrate the use of the species
for studying neurological function in a model of human disease. We show that electroencephalography can be used in sheep, and that
longitudinal recordings spanning many months are possible. This is the ﬁrst time such an electroencephalography study has been
performed in sheep. We characterized sleep in sheep, quantifying characteristic vigilance states and neurophysiological hallmarks
such as sleep spindles. Mild sleep abnormalities and abnormal epileptiform waveforms were found in the electroencephalographies of
Battendisease affected sheep.These abnormalities resemble the epileptiformactivity seen in childrenwithBattendisease anddemonstrate
the translational relevance of both the technique and the model. Given that both spontaneous and engineered sheep models of human
neurodegenerative diseases already exist, sheep constitute a powerful species inwhich longitudinal in vivo studies can be conducted. This
will advance our understanding of normal brain function and improve our capacity for translational research into neurological disorders.
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Introduction
Neuroscientists rely on using animals, particularly mice,
as models in which to study normal brain function, dis-
ease-related neuropathophysiology and drug action on the
brain. Modelling of progressive neurological diseases such
as Alzheimer’s and Parkinson’s disease, however, remains
particularly challenging, with mice either not developing
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the relevant pathology or doing so at such a late stage in
their lives that they cannot be used effectively (LaFerla and
Green, 2012; Pouladi et al., 2013; Webster et al., 2014).
The value of using large-brained animals, particularly for
the development of new therapies, is recognized increas-
ingly (Morton and Howland, 2013; Dolezalova et al.,
2014). In the case of CLN5 Batten disease, for example,
while transgenic mice develop some pathologies relevant to
Batten disease (Kopra et al., 2004), the genetically equiva-
lent CLN5 / affected Batten disease sheep (Jolly et al.,
2002; Frugier et al., 2008), and cattle (Harper et al.,
1988; Houweling et al., 2006) models show pronounced
pathologies that more closely recapitulate the human dis-
ease (for review, see Jolly et al., 1992).
Many potential treatments, particularly growth factors
and gene therapies, depend on direct delivery to the brain
and distribution within the brain by diffusion. Although
such therapies may work well in mice where the distance
from delivery site to destination is small, many fail to reach
their target in the large human brain (Schubert et al.,
2008). Therefore, a large-brained animal model is an im-
portant stepping-stone for developing therapies that will
necessitate direct delivery routes.
Although non-human primates are considered superior to
other laboratory animals for translational studies, experi-
mentation with these poses challenges, not only in the eth-
ical domain, but also in practical management (Morton
and Howland, 2013). Maintaining the animals safely,
high costs and difﬁculty in managing the large numbers
that may be required to generate appropriate statistical
power already restrict the use of non-human primates to
specialist laboratories, where only small numbers can be
used to good effect. Thus, opportunities for preclinical
work on large-brained animals are limited, unless we con-
sider using other species.
Sheep have been used as models for deep brain stimula-
tion (Stypulkowski et al., 2011), in basic brain function
studies (Kendrick et al., 2001), and as models of brain
injury (Grimmelt et al., 2011). A number of neurodegen-
erative diseases have been found in sheep, including three
ﬂocks with different forms of the neuronal ceroid lipofus-
cinoses (hereafter referred to as Batten disease; Jolly et al.,
2002; Frugier et al., 2008; Bond et al., 2013). Other sheep
models include experimentally-induced models such as
transmissible spongiform encephalopathies (Table 1), and
the recently developed transgenic Huntington’s disease
model (Jacobsen et al., 2010).
Sheep are an attractive species for the study of brain
function (Morton and Howland, 2013). Like non-human
primates, they have large brains with convoluted neocor-
tices and human-like basal ganglia with anatomically dis-
tinct caudate and putamen. They are domesticated,
accustomed to human handling and their husbandry is
straightforward. Being social animals, they are normally
kept in ﬂocks allowing relatively easy ‘scale-up’ of groups
to large numbers. Finally, their relatively long life
span (410 years) makes them more appropriate than
short-lived rodents for studies of progressive human neuro-
logical diseases, such as Alzheimer’s disease and
Huntington’s disease.
In this study we investigated the feasibility of using sheep as
in vivo models for chronic, untethered monitoring of brain
activity, both in normal sheep and sheep with clinically ap-
parent Batten disease. We used clinically affected CLN5
Batten disease sheep because they show abnormal behaviour
and neurological features (Jolly et al., 2002; Frugier et al.,
2008), that recapitulate those seen in human sufferers (A˚berg
et al., 2011). We hypothesized that brain activity abnormal-
ities such as sleep deﬁcits and epileptiform activity might also
be observed in CLN5 / affected Batten disease sheep.
Techniques were developed for longitudinal in vivo record-
ings of electroencephalography (EEG) in naturalistic environ-
ments in the presence of conspeciﬁcs. Twenty-four hour
recordings were used to classify vigilance states and charac-
teristic mammalian hallmark sleep signatures were quanti-
ﬁed. It is notable that patients with Batten disease suffer
from feeding and swallowing abnormalities as well as other
motor-related abnormalities (A˚berg et al., 2011).
Accordingly, we also investigated the potential for using ru-
mination (a physiological process that heavily relies on coor-
dinated regurgitation, mastication and swallowing and is
readily observed in sheep) as a read-out for centrally con-
trolled complex motor behaviour.
Materials and methods
Animals
CLN5 affected (CLN5 /) and heterozygous control
(CLN5 + /) Borderdale sheep with a c.571 +1G4A splice
site mutation (Frugier et al., 2008) were obtained from
Lincoln University, New Zealand (NZ), where they had been
bred and reared under procedures approved by the Lincoln
University Animal Ethics Committee in compliance with the
NZ Animal Welfare Act (1999) and in accordance with US
National Institutes of Health guidelines. Sheep were shipped
by air from NZ to the UK, where experiments were started
after a 3-month acclimation period. All procedures were con-
ducted in accordance with the UK Animals Scientiﬁc
Procedures Act (1986) and the University of Cambridge ethical
review board. Because such EEG studies in sheep have never
been previously conducted, power analyses could not be per-
formed. We determined the number of animals to use empir-
ically. Five healthy Welsh Mountain ewes were used to
establish the techniques (mean age at implantation 10  0.8
months), and ﬁve homozygous (CLN5 /) and two heterozy-
gous (CLN5 + /) Borderdale sheep carrying the CLN5 gene
mutation were used to investigate electrophysiological pheno-
types associated with the genetic mutation (mean age at im-
plantation 14.3  0.5 months). The two (unaffected)
CLN5 + / sheep were age-matched ﬂock mates of the
CLN5 / affected Batten disease sheep. They were included
to exclude the possibility that there were major breed or age
differences that could account for the differences between the
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normal Welsh mountain sheep and the CLN5 / Batten dis-
ease affected sheep.
Sheep were housed outdoors in a paddock until implant-
ation, at which point they were transferred to a barn with
windows and supplementary artiﬁcial light (6 am to 6pm).
All sheep had access to hay feed and water ad libitum and
an additional pellet supplement was supplied between the
hours of 8–9 am. Sheep behaviour was observed daily, and
abnormal behaviours recorded. Sheep were weighed at least
once a week.
Surgery
Food was withheld for a period of 12 h before surgery.
Anaesthesia was induced intravenously using Alfaxalone
(Alfaxan, Jurox) at 3mg/kg and maintained using an isoﬂur-
ane/oxygen/nitrous mixture delivered through a Manley venti-
lator (stroke volume 300ml and ventilation rate 15–20/min).
Isoﬂurane was maintained at 2–3%, end-tidal CO2
at 25–30mmHg and mean arterial blood pressure at
70–90mmHg. Intravenous ﬂuids were supplied at a rate of
5ml/kg/h (lactated Ringers, Hartmann’s Solution 11 by
Aquapharm). Vital functions were recorded at 5-min intervals,
and blood gases sampled every 30min throughout the
procedure.
Under aseptic conditions, a midline incision was made from
the midpoint of the interaural line to the occipital end of the
skull. Excessive bleeding was stemmed using electrocautery.
Using blunt dissection the cranial skin was retracted and the
scalp scraped to remove all connective tissue. The skull was
cleaned with 3% hydrogen peroxide, and immediately rinsed
with sterile saline spray. Craniotomies were drilled 10mm
either side of the midline on both hemispheres, at positions
30, 20 and 10mm anterior and 10mm posterior to ‘bregma’
(Fig. 1A). We deﬁned bregma as being the intersection of the
midline skull suture separating the frontal bones, and the
transverse suture between the frontal and parietal bones i.e.
where frontal and posterior cranial bones meet, that would be
equivalent to bregma in a primate. Intracortical needle elec-
trodes were then inserted and secured with plastic screws. Two
electrodes were placed in the neck muscle for EMG recording
and two electrodes at the outer medial canthi of the left eye for
electrooculogram (EOG) recording. EOG electrodes were tun-
nelled subcutaneously and EMG wires were sutured to the
neck muscles. All EEG electrodes were secured in place with
sterile bone cement containing gentamicin (Depuy CMW2,
Johnson & Johnson, UK). Electrodes were bundled together
and terminated at an Omnetics Micro circular connector
(Omnetics Corporation) that was exteriorized through a
purse suture opening at the neck area. The rest of the incision
was sutured and the whole incision was sealed with a wound
plaster spray (Kruuse Wound Plast). After surgery, the animals
were allowed to recover for 7–10 days in their home environ-
ment, at which time sutures were removed and recordings
commenced.
Data acquisition
Sheep were ﬁtted with jackets that carried a paediatric ambu-
latory EEG ampliﬁer (Siesta 802, Compumedics) (Fig. 1B).
Table 1 Sheep models of human neurological disorders
Human disease Gene Description
Neuronal ceroid lipofuscinosis (Variant late-
infantile Batten diseases)
CLN5, CLN6 Naturally-occurring neuronal ceroid lipofuscinoses
Neuronal ceroid lipofuscinosis variant
(congenital)
CTSD (cathepsin D) Naturally-occurring neuronal ceroid lipofuscinosis
McArdle disease PYMG Naturally-occurring metabolic muscle disorder
Hereditary lissencephaly and cerebellar
hypoplasia
RELN Naturally occurring lissencephaly
Neuroaxonal dystrophy ? Naturally-occurring muscular dystrophy
Gaucher disease b-glucocerebrosidase Naturally-occurring lysosomal storage disease
Adult-onset Alexander disease GFAP Naturally-occurring hypereosinophilic, intra-astrocytic inclusions
(Rosenthal fibres)
Tay-Sachs disease G(M2) activator protein Naturally-occurring GM2 gangliosidosis
Huntington’s disease HTT Transgenic sheep model (OVT73)
Hereditary cerebellar ataxia (Murrurindi
disease)
? Naturally-occurring encephalopathy
Brachygnathia, cardiomegaly and renal hypo-
plasia syndrome
? Naturally-occurring multisystem disorder
Chronic binge alcohol-induced cerebellar
injury
- Induced model of foetal alcohol syndrome
Middle cerebral artery occlusion - Induced model of stroke
Transmissible spongiform encephalopathy PRNP Infectious model of bovine spongiform encephalopathy, variant
Creutzfeld Jacob disease and other prion diseases
Head trauma - Induced model of shaken baby syndrome
Schizophrenia - Infectious model of in utero endotoxaemia
Type 2 diabetes - Induced model of diabetes
Pre-natal global hypoxia - Induced model of hypoxic brain damage
? = gene not known.
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Figure 1 Implantation technique and example EEG traces from each vigilance state in sheep. (A) Intracortical needles were
implanted and secured on the skull on both hemispheres, at the points shown by the black dots on the right side of the skull and equivalent
positions on the left hand side. Coordinates were determined with reference to the intersection (red dot) of the transverse suture that separates
the frontal (F) and parietal bones (P) and the midline suture that separates the frontal bones. Suture positions are indicated by the dotted lines.
Part of the left side of the skull has been removed to show the brain in situ: the dorsal surface of the cortex (Co) and the cerebellum (CB) are
partially visible. Bipolar EOGs were obtained from electrodes placed at the inner and outer canthi of the right eye (EOG1 and EOG2), while
bipolar EMGs were attached to the dorsal neck musculature (not shown). (B) Electrodes were exteriorized on the back of the neck and
terminated in a single connector (black arrow). The amplifier (Amp) was housed within a pouch on the sheep jacket. (C) Recordings were made
from animals in their home pens in the presence of conspecifics. Example traces (D–H) obtained from a normal sheep show characteristic EEG
(upper trace), EOG (middle trace) and EMG (lower trace) associated with the vigilance states of Wake (D), non-REM (F) and REM sleep (H) that are
typically seen in non-human primates. Additional sheep-specific states were identified: rumination (Rum; E) and rumination with concurrent slow-
wave EEG activity (Rum + non-REM; G). (I) The amount of time spent in each vigilance state is shown. Data are means  SEM. Scale bars: A = 3
cm; D = 0.5 s; D–H = 300 mV.
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Total weight of instrumentation was 1.2 kg (compared to
the average body weight of sheep at this age of 40 kg).
Previous work has established that similar harness equipment
carried by sheep did not affect sheep locomotion (Hobbs-Chell
et al., 2012). All channels were sampled at 256 Hz and hard-
ware-ﬁltered between 0.15–128Hz. Twenty-four hour record-
ings were obtained and stored on board the ampliﬁer. Infrared
video recordings were collected through a wall-mounted
camera covering most of the accessible environment.
Data analysis
Sleep EEG and rumination analysis
The criteria for vigilance state classiﬁcation are detailed in
Supplementary Table 1. Wake activity was characterized by
fast, low amplitude (580 mV) EEG, and large amplitude vari-
able EMG and eye movements as measured by the EOG. Non-
REM sleep was characterized by EEG with large amplitude
(4100 mV) slow-wave oscillations in the delta frequency
band (0.5–4Hz), a reduction of EMG tone and a ﬂat EOG.
REM sleep was characterized by a further reduction in muscle
tone, a wake-like EEG and occasional eye movements. Only
epochs that followed the non-REM state were classiﬁed as
REM. Rumination was characterized by wake-like EEG,
EMG free of movement artefact and clear rhythmic chewing
in the EOG. Rumination + non-REM was characterized by
EEG consistent with non-REM sleep, an artefact-free EMG
and an EOG consistent with rumination.
EEG, EOG and EMG channels were used for vigilance state
classiﬁcation in conjunction with behavioural monitoring
through video recording. EEG, EMG and EOG channels
were bandpass-ﬁltered between 0.5–40Hz. The 24-h record-
ings were analysed in 10-s intervals (epochs) and each assigned
a vigilance state according to the criteria listed in
Supplementary Table 1. Spectral analyses of non-REM
epochs were performed using multi-tapered spectral analysis
methods as realized in the Chronux Toolbox (http://chronux.
org/) with a time-bandwidth product of three and ﬁve tapers.
Automated detection of slow-waves, spindle and
seizure events
Automated detection routines as described by Phillips et al.
(2012) were used. Brieﬂy, spindle-band ﬁltered and rectiﬁed
waveforms were standardized and an amplitude threshold de-
tection routine, realized in Matlab (R2010B, Mathworks)
was used to detect events exceeding the threshold of 1.5 stand-
ard deviations. Additional heuristic criteria were used to select
a subpopulation of these events (presence of an autocorrelation
peak in the range 0.0625–0.117 s, length smaller than 600ms
and amplitude not exceeding  100mV) and all events were
conﬁrmed to be spindles through visual inspection. Slow-
waves were detected with a similar detection algorithm (amp-
litude threshold of two standard deviations) but with EEG
waveforms ﬁltered in the 0.5–3Hz band and an additional
rejection criterion (amplitude not exceeding  300mV).
Spindle band activity around slow-waves was calculated by
forming averages of spindle-band ﬁltered, rectiﬁed and
smoothed waveforms centred on the peaks of slow-wave
events (from 1 to + 1 s around corresponding slow-waves).
Seizures were automatically detected by the algorithm used for
spindle detection but with ﬁltering in the 4–6Hz frequency
band and a threshold of two standard deviations. A subselec-
tion of events was chosen using two component Gaussian mix-
ture clustering of features extracted within the threshold-
detected events (features: raw signal autocorrelation, root
mean square amplitude, ratio of power in 4–6Hz to the re-
maining spectrum and absolute power in the 4–6Hz band).
The clustering step facilitated the separation of threshold-de-
tected events into seizures and artefacts.
Verifying concurrent rumination and non-REM sleep
using independent component analysis
Because of occasional EEG contamination by rumination-related
chewing, we performed independent component analysis on all
acquired channels (EEG, EMG and EOG) to verify whether ru-
mination and slow-wave activity were linearly separable. Using
the ‘runica’ algorithm of the EEGLAB toolbox (Delorme and
Makeig, 2004) independent components associated with rumin-
ation were visually identiﬁed and then subtracted from all EEG
channels (but not from EMG or EOG channels).
Rumination
Epochs marked as rumination were subsequently analysed in
terms of numbers of episodes, episode durations, bout length
variability and the variability in duration of intervals between
consecutive chewing events. Bout lengths were calculated for
all sheep. We drew a random sample of 300 bout events from
each sheep and calculated standard deviations as a measure of
variability. A similar approach was followed for the assess-
ment of inter-chewing intervals but with a sample of 12 000
events from each sheep.
Statistical analysis
T-tests were used where the homogeneity of variance was met
(Levene’s test of equality of variance). To assess diurnality in
normal and CLN5 / Batten disease affected sheep, pairwise
t-tests were used to compare the amount of time spent in the
wake states during the day versus the night. To compare the
time spent in each stage for each vigilance state, a two-group
(normal versus CLN5 / Batten disease affected sheep) by
ﬁve-vigilance states (wake, rumination, rumination + non-
REM, non-REM and REM) multivariate analysis of variance
(MANOVA) was used. The slow wave characteristics of ampli-
tude and peak frequency, the spindle amplitude and spindle dens-
ity and slow-wave locked spindle band activity during non-REM
sleep were compared using t-tests. Slow wave amplitude data
were inversely-transformed to achieve normality. The number
of rumination episodes, variability in rumination bout lengths
and variability in inter-chewing intervals were assessed using t-
tests. Statistical tests were considered signiﬁcant at P50.05.
Results
Sheep are easily managed experi-
mental subjects for chronic brain
implants
The large skull and brain size of sheep allow many electrodes
to be surgically implanted (Fig. 1A). Sheep recovered well
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from surgery. Within a few minutes from the end of anaes-
thesia sheep were eating and within an hour they were stand-
ing up. They were then returned to their normal group
housing. No overt behavioural changes were observed after
recovery from surgery. Animals were instrumented with jack-
ets that held standard ambulatory paediatric EEG recording
devices (Fig. 1B), so EEGs could be recorded from sheep in
their home pen in the presence of conspeciﬁcs (Fig. 1C). The
instrumentation was well tolerated and long continuous
recordings could be collected. We were able to collect good
quality 24-h data for up to 280 days after implantation
(Supplementary Fig. 1).
Sheep are diurnal and exhibit five
states of vigilance
Vigilance states were visually classiﬁed using electrophysiolo-
gical measures and further corroborated using behavioural
criteria obtained through 24-h video monitoring
(Supplementary Table 1). All sheep exhibited the characteris-
tic mammalian vigilance states of wake, REM and non-REM
sleep (Fig. 1D–H). Sheep are ruminants and so spend a sig-
niﬁcant amount of time chewing previously ingested and
regurgitated food. They ruminate when free from threat and
almost exclusively while seated. Thus, we classiﬁed rumin-
ation as a distinct vigilance state (Fig. 1E). In line with previ-
ous observations of ruminant sleep (Bell and Itabisashi, 1973;
Ruckebusch, 1975), we identiﬁed an additional state of ru-
mination accompanied by EEG slow-wave oscillations con-
sistent with non-REM sleep (rumination + non-REM; Fig.
1G, see also Supplementary Videos 1 and 2 for distinct be-
haviours during these two states).
Visual inspection of the EEG traces revealed slowwave activ-
ity temporallyoverlappingwithchewing-inducedartefacts aris-
ing from mastication activity during rumination
(Supplementary Fig. 2A and B). As it was occasionally difﬁcult
todiscernwhether thesetwoprocesseswereindependentofeach
other, we used independent components analysis to assess
whether slow wave oscillations and rumination artefacts
were linearly separable. Through independent component ana-
lysisdecomposition, the identiﬁedruminationrelated independ-
ent componentswere subtracted fromtheEEGtraces leavingan
artefact-free EEG. As a result, both wake-like (Supplementary
Fig. 2G) and non-REM-like (Supplementary Fig. 2H) EEG ac-
tivitycouldbedetected.Artefact-freeEEGchannels remainedso
after subtraction of rumination components (Supplementary
Fig. 2C and D before subtraction; I and J post subtraction).
Thus, slow wave-like oscillations during rumination intervals
arise from statistically independent processes.
Behavioural and neurological pheno-
types of CLN5 / Batten disease
affected sheep
As previously described (Jolly et al., 2002; Frugier et al.,
2008), CLN5 / Batten disease affected sheep show a
slowly progressing neurological phenotype that includes de-
terioration of vision, reduced awareness (manifest by self-
segregation from the ﬂock and irruptive bumping into obs-
tacles), tremor (observed in eyelids, ears and hind limbs)
and motor deﬁcits (locomotion difﬁculties and stumbling).
Additional behavioural changes that we noted included an
unusually low head carriage, stargazing, repetitive behav-
iours (teeth grinding and compulsive circling), and feeding
difﬁculties (slow, inefﬁcient eating and dribbling). These
resembled behavioural signs reported for CLN6 Batten dis-
ease affected sheep (Cook et al., 2002). It should be empha-
sized that the CLN5 / Batten disease affected sheep used
here showed only mild overt signs at the end of the study
period. Furthermore, they had not lost signiﬁcant body
weight. Indeed, their body weight proﬁle was similar to
their heterozygote counterparts. Linear regression on aver-
age weights collected for each genotype group during the
study revealed similar positive slopes (0.132 for CLN5 /
and 0.187 for CLN5 + / ), indicating that both groups of
sheep were still growing at similar rates.
CLN5 / Batten disease affected
sheep show reduced sleep and
decreased peak EEG delta power
Clinically, sleep phenotypes are characterized in terms of
sleep architecture (the relative proportions and timing of
different sleep stages) and sleep neurophysiology, both of
which are disrupted in a range of brain diseases (Wulff
et al., 2010). We therefore translated these measures into
the sheep model. Quantiﬁcation of vigilance states (Fig. 1I)
showed that normal and CLN5 / Batten disease affected
sheep exhibited diurnal behaviour consistent with previous
reports of sheep housed under similar conditions (Tobler
et al., 1991; Piccione et al., 2008) with signiﬁcantly
more wakefulness during day-time (mnorm = 81.4  2.1%;
mCLN5/ = 89.0  2.9%) than during night-time
(mnorm = 55.3  7.2%; mCLN5 / = 67.3  4.6%; normal:
t = 4.590, df = 4, P = 0.010; CLN5 /: t = 8.470, df = 4,
P = 0.001).
A two-group (normal versus CLN5 / Batten disease
affected sheep) by ﬁve-vigilance states (wake, rumination,
rumination + non-REM, non-REM and REM) MANOVA
revealed that the time spent in wake and rumination (ru-
mination and rumination + non-REM together) did not
differ between groups. However, the time spent in non-
REM and REM states was signiﬁcantly shorter for the
CLN5 / sheep (non-REM: mnorm = 16.2%  1.7% and
mCLN5/ = 10.1%  1.6%; f = 7.782, df = 1, P = 0.024 and
REM: mnorm = 2.2%  0.4% and mCLN5 / = 0.7%  0.2%,
f = 9.012, df = 1, P = 0.017).
EEG during sleep features ‘hallmark’ neural network os-
cillations with dissociable origins and frequencies.
Quantiﬁcation of these oscillations provides a direct
metric of circuit function and dysfunction during sleep.
The most prominent EEG features during non-REM sleep
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include slow-wave activity (0.1–4Hz), reﬂecting synchro-
nized transitions between cortical UP and DOWN states,
and thalamocortical spindle oscillations (8–15Hz) that
shape ensemble activity and plasticity (Diekelmann and
Born, 2010).
We examined slow-wave activity during non-REM sleep
using detection of individual slow-wave events alongside
Fourier analyses (Fig. 2). Figure 2A shows typical examples
of high amplitude EEG during non-REM sleep from normal,
CLN5+ / and CLN5 / sheep. The latter group clearly
displays lower slow-wave amplitude. Accordingly, non-
REM peak slow-wave band (0.5–4Hz) power was signiﬁ-
cantly lower in CLN5 /sheep (mnorm = 737.9  164.9mV2
and mCLN5/ = 169.3  61.2mV2; t = 4.378, df = 8,
P = 0.002; Fig. 2B and C). Furthermore, the non-REM
peak frequency in slow-wave band activity was signiﬁcantly
higher in CLN5 / sheep than in normal sheep
(mnorm = 0.98  0.11Hz and mCLN5 / = 1.28  0.08Hz;
t = 2.326, df = 8, P = 0.049). In CLN5+ / sheep, both
peak slow-wave band power and frequency, and slow-
wave amplitudes were qualitatively more similar to normal
sheep than CLN5 /. Because of the small sample size
of CLN5+ / animals, statistical comparisons were not
attempted.
Sheep sleep is rich in sleep spindles
and these remain relatively
unaffected in CLN5 / Batten disease
affected sheep
Spindle band activity is a hallmark of light non-REM sleep
and, critically, is implicated in the memory-consolidating
function of sleep (Eschenko et al., 2006). In humans,
changes in sleep spindles have been identiﬁed as phenotypic
markers in neurological conditions such as Huntington’s
disease (Wiegand et al., 1991), schizophrenia (Ferrarelli
et al., 2007), Alzheimer’s disease (Rauchs et al., 2008),
and Parkinson’s disease (Christensen et al., 2014). Here,
we characterized the nature of sleep spindles and their tem-
poral relationship with slow-wave activity in both healthy
and diseased sheep.
EEG from non-REM epochs was band-pass ﬁltered at the
spindle frequency range (10–16Hz) and spindle events were
detected using a threshold detection algorithm (see ‘Materials
and methods’ section). To obtain a representative sample of
spindle events (Fig. 2D), 200 spindles were randomly selected
from each sheep and the absolute amplitude within the 0.8 s
window was integrated (Fig. 2E). There was a trend towards
lower spindle amplitude in CLN5 / Batten disease affected
sheep (mnorm = 1636  259mV and mCLN5 / = 900  197mV,
t = 2.257, df = 8, P = 0.054). Spindle density and duration did
not differ between groups.
We next examined the interrelationships between slow-
waves and spindles, which reﬂect coordinated limbic-cor-
tical activity during non-REM sleep (Hahn et al., 2006;
Taxidis et al., 2013). Using similar threshold detection al-
gorithms, slow-wave events (0.5–3Hz) were detected and
the envelope of the spindle band activity around these
events was computed (Fig. 2C and E). The absolute slow-
wave-associated spindle band activity was signiﬁcantly
lower in CLN5 / sheep (mnorm = 13.8  2.8 mV and
Figure 2 Power spectra and sleep spindles recorded
during non-REM sleep are abnormal in CLN5 / sheep.
(A) Example EEG traces show high-amplitude non-REM sleep re-
corded from a normal (blue), heterozygous CLN5+ / (black) and
homozygous CLN5 / (red) sheep. Large slow-waves are visible in
recordings from normal and CLN5+ / sheep (black trace), but not
in those recorded from CLN5 / sheep (red trace). (B) Power
spectra from recordings during non-REM sleep show lower peak
delta amplitude and increased activity in the range of 3–5 Hz for
CLN5 / sheep (red trace) compared to both normal (blue trace)
or CLN5+ / sheep (black trace). (C) Slow-waves detected auto-
matically had lower amplitudes in CLN5 / compared to either
normal or CLN5+ / sheep. (D) Sleep spindles during non-REM
sleep were observed in all sheep. Examples show spindle events
from normal (a and b) and CLN5 / sheep (c), either with (a and b)
or without (c) an adjacent slow-wave. (E) Average detected spindles
in CLN5 / sheep (red trace) seemed to have smaller amplitudes
than those of normal sheep (blue trace), but the difference did not
reach statistical significance. Spindles from CLN5+ / sheep were
similar to those from normal sheep (not shown for clarity). (F) Slow
wave-triggered and rectified spindle band activity showed an in-
crease in the vicinity of slow waves in normal (blue) and CLN5+ /
sheep (black) that was not seen to the same extent in CLN5 /
sheep (red). The scale bar in A applies to all three traces and
represents 1 s (x-axis) and 200 mV (y-axis); scales in D are 0.25 s (x-
axis) and 50mV (y-axis).
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mCLN5 / = 6.5  0.8mV, t = 2.452, df = 8, P = 0.040), sug-
gesting disrupted coordination of thalamocortical activity
during non-REM sleep. Because of the small sample size
(with only two CLN5+ / sheep), we did not compare
data statistically. Nevertheless, data from CLN5+ / sheep
were qualitatively more similar to normal sheep than they
were to CLN5 / animals. In all, these results are analo-
gous to human neurological ﬁndings, suggesting that the
study of sleep spindles in sheep may be a useful transla-
tional measure in ovine neurodegenerative models.
CLN5 / Batten disease affected
sheep suffer from frequent, short
duration, non-manifest seizures
Children affected by CLN5 Batten disease frequently de-
velop epilepsy (Jadav et al., 2014). As well as this, EEG
abnormalities during non-REM sleep are seen in patients
with Batten disease who do not have convulsive seizures
(Lauronen et al., 1999). Overt seizures are not a feature
of ovine CLN5 Batten disease, and no manifest seizures
have been reported in ﬁeld observations of 4100
CLN5 / sheep in the founder ﬂock at Lincoln
University, a number of which were over 22 months of
age. Although none of our sheep showed manifest convul-
sive seizures, EEG revealed frequent epileptiform activity in
all recordings from CLN5 / Batten disease affected sheep.
These events were observed in some sheep as early as 8
months, when recording ﬁrst started, and were present in
all affected sheep. Importantly, none of the recordings from
CLN5 + / or normal sheep exhibited these events.
Epileptiform events were automatically detected (see
‘Materials and methods’ section for detection routine) in
the frequency range of 4–5Hz. Figure 3A shows examples
of epileptiform ictal events recorded from CLN5 / Batten
disease affected sheep. These events were typically non-
manifest (i.e. no instances of convulsive seizures were
Figure 3 Epileptiform events were observed exclusively in EEGs from CLN5 / Batten disease affected sheep. (A) Typical
examples of EEG recordings during epileptiform activity. (B) Epileptiform events are seen in the EEG without concomitant EOG or EMG
components. (C) Normalized power spectra during epileptiform events show a peak at 4.5 Hz. (D) Epileptiform events were typically short, with
a median duration of 2.5 s. (E) Events were seen in all vigilance states at similar rates in each state. (F) Spectral content of these events was similar
across vigilance states, with a peak at 4.5 Hz. NREM = non-REM; Rum = rumination.
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recorded) as revealed by an absence of high amplitude cor-
related EMG and EOG activity (Fig. 3B). An average poly-
spike discharge rate of 4.5Hz was observed (Fig. 3C), with
a mean duration of 2.5 s (Fig. 3D). Events were observed in
all vigilance states (Fig. 3E). Peak normalized power was
similar across vigilance states (Fig. 3F).
Abnormalities in rumination may
serve as a read-out for motor
dysfunction in sheep
Neurodegenerative conditions are often accompanied by
symptoms involving motor control manifested as dysphagia
or dysarthria (A˚berg et al., 2011; Heemskerk and Roos,
2011; Monteiro et al., 2014). Rumination is a complex
behaviour requiring both peripheral and central control
mechanisms (Baile et al., 1967; Honde and Bueno, 1984):
in order to ruminate, sheep must initiate and maintain a
complex motor sequence involving regurgitation, mastica-
tion and swallowing of food for long periods extending
tens of minutes. Given the motor component of rumin-
ation, we investigated the use of EMG and EOG activity
during rumination as a potential marker of motor
dysfunction.
In both normal and CLN5 + / sheep, rumination was
found to be highly temporally structured, with consistent
bout lengths and chewing rhythmicity (Fig. 4A–C and E).
By contrast, rumination in CLN5 / Batten disease af-
fected sheep was marked by much less consistent bout
and chewing intervals (Fig. 4B–D and F). We therefore
quantiﬁed rumination across three temporal scales (episode,
bout and inter-chewing durations). CLN5 / Batten dis-
ease affected sheep had a signiﬁcantly higher number of
rumination episodes (mnorm = 20.2  1.4 and mCLN5/
= 31.4  3.1, t = 3.317, df = 8, P = 0.011) and these were
signiﬁcantly shorter than those seen in normal sheep
(mnorm = 66.8  4.9 min and mCLN5 / = 38.4  2.9 min,
t = 5.02, df = 8, P = 0.001). We calculated the standard de-
viation of each sheep’s bout length distribution as an index
of variability of bout duration. CLN5 / Batten disease
affected sheep had signiﬁcantly higher bout variability com-
pared to normal sheep (mnorm = 7.3  1.2 and mCLN5 /
= 11.1  2.7, t = 2.86, df = 8, P = 0.021), as illustrated in
Fig. 4B, although no difference was detected in the variabil-
ity of inter-chewing intervals (P = 0.113; Fig. 4C).
Together, these results identify rumination as a potential
marker for motor dysfunction in sheep. Additionally, the
observation that rumination events can be interrupted by
epileptiform activity (Fig. 4G) supports the idea that
Figure 4 Rumination is a highly structured temporal process that is abnormal in CLN5 / affected Batten disease sheep.
(A) Typical examples of rumination episodes (EOG) from normal sheep show regular bouts of chewing. The distribution of chewing bout lengths
(B) and interchewing intervals (C) in normal (blue) and CLN5+ / sheep (black) are similar. (D) Rumination in CLN5 / sheep shows increased
variability (B) in bout lengths but similar interchewing intervals (C), compared to normal or CLN5+ / sheep. (E) A higher resolution portion of
rumination from a normal sheep reveals the rhythmic chewing associated with rumination. (F). Chewing is more variable in the example from a
CLN5 / sheep; overall this was not statistically significant. (G) An example of a myoclonic event with epileptiform spike discharges interrupting
rumination.
870 | BRAIN 2015: 138; 862–874 N. Perentos et al.
 by guest on June 22, 2016
http://brain.oxfordjournals.org/
D
ow
nloaded from
 
disturbances to an integrated cortico-brainstem network
controlling rumination-related motor activity cause the
abnormalities.
Discussion
Recording EEGs from a cohort of sheep carrying a natural
mutation in CLN5 that causes variant late-infantile Batten
disease uncovered neurological abnormalities characteristic
of those seen in children with CLN5 or other forms of late
infantile Batten disease, including reduced EEG amplitude
and frequent epileptiform activity (Harden and
Pampiglione, 1982; Veneselli et al., 2000; Jadav et al.,
2014). Quantiﬁcation of the unique feature of rumination
showed that CLN5 Batten disease affected sheep have deﬁcits
which may arise from motor control abnormalities; therefore
this marker may serve as a useful readout of disease progres-
sion in sheep with Batten or other neurological diseases.
All of the sheep EEGs were collected via surgically im-
planted electrodes, because artefacts from the large muscles
made it impossible to collect EEG from surface or subcuta-
neous electrodes (unpublished observations, N.P. and
A.J.M.). Nevertheless, for humans EEG is particularly ap-
pealing as a measure of human brain activity because of its
non-invasive nature and low cost. Our analyses concen-
trated on EEG features that are readily detectable through
scalp EEG recordings in humans, ensuring translational
relevance. The method has great potential, since EEG ﬁnd-
ings in humans can now be studied in a large genetically-
relevant sheep model. EEG can be used as a longitudinal
biomarker, or combined with experimental interventions to
provide important directions for therapeutic development.
The technique developed here allows sleep-wake EEG
recordings to be conducted on unrestrained sheep under
naturalistic housing conditions in which they are behaving
normally. Recordings can be conducted longitudinally (see
Supplementary Fig. 1 for an example of a series of longi-
tudinal recordings from one animal, with comparable
signal amplitudes, extending up to 280 days post-implant-
ation). Thus EEG changes might be useful as a marker of
disease progression. Further studies will be necessary to
establish this possibility.
Using our EEG methods, sheep are able to express their
normal sleep-wake proﬁles, uncontaminated by stress from
restraint or removal from home environments, or by the
need to carry cumbersome equipment that may affect be-
haviour. Our 24-h recordings conﬁrmed that sheep are di-
urnal, with sleep-wake characterized by recognizable
vigilant states. They typically had a total amount of sleep
of 5 h. The small amount of REM sleep identiﬁed was
surprising, but consistent with earlier studies where total
REM in sheep ranged from 1–2.5% (Ruckebusch, 1972;
Ruckebusch and Gaujoux, 1976). A hypothesis explaining
the low amount of REM sleep in sheep suggested that the
ruminant stomach requires an upright position of the
thorax for proper functioning, imposing postural
constraints on the animal that limit the opportunities for
fully reclined sleep (Balch, 1955). The prey nature of the
species and its inability to hide effectively from predators
may have also exerted evolutionary pressure on its sleep
physiology (Allison and Cicchetti, 1976; Capellini et al.,
2008).
Our ﬁndings of decreased non-REM EEG amplitudes in
Batten disease affected sheep are consistent with those re-
ported from patients with the juvenile form of Batten dis-
ease, who display a relative increase in the percentage of
sleep spent in stage 1 slow-wave sleep while overall sleep
quantity is reduced (Kirveskari et al., 2000). Mean age dif-
ferences between normal and CLN5 Batten disease affected
sheep are unlikely to account for the observation of
reduced non-REM EEG amplitudes. The heterozygous un-
affected sheep recorded at the same age as the CLN5 /
Batten disease affected sheep presented electrophysiological
signatures that were much more similar to normal sheep
than to CLN5 / Batten disease affected sheep. The ob-
servation of reduced slow-wave amplitudes during non-
REM sleep can be interpreted in several ways. First,
reduced non-REM amplitudes could be interpreted as a
decrease in homeostatic sleep drive reﬂecting a reduced
need for sleep; this would be consistent with the accom-
panying reduction in the overall amount of non-REM
sleep. The synaptic downscaling hypothesis argues that a
prominent function of non-REM sleep is to downscale pre-
viously potentiated cortical connections that result from
daytime experience and that the non-REM slow-wave amp-
litude reﬂects this need (Tononi and Cirelli, 2014). We
speculate that in CLN5 / sheep, because of the learning
deﬁcits, dementia and blindness normally associated with
Batten disease, there is decreased synaptic upscaling during
the day and, accordingly, decreased need for synaptic
downscaling during sleep. This would result in depressed
slow-wave amplitude during non-REM sleep.
Second, it is also likely that the reduced slow-wave amp-
litude results from neuronal loss or defective recruitment of
neurons into the slow-wave oscillation. This possibility is
consistent with observations of atrophied cortices in CLN5
patients with Batten disease (Petersen et al., 1996; Tyynela¨
et al., 1997; Pen˜a et al., 2001) and CLN5 / affected
Batten disease sheep (Jolly et al., 2002). The shift of
slow-wave spectra towards faster frequencies seen in
CLN5 / affected Batten disease sheep may arise from
an imbalance between inhibition and excitation in cor-
tico-thalamocortical loops. This would be consistent with
a selective loss of GABAergic interneurons in the cortex,
the reticular thalamic nucleus and other thalamic nuclei as
has been described in CLN5 mice (Kopra et al., 2004) and
CLN6 sheep (Oswald et al., 2008).
We have characterized sheep sleep and found a number
of features that make sheep attractive models for studying
sleep, particularly when compared with rodents. Sheep are
diurnal animals, as are primates, whereas rodents are noc-
turnal. We have observed that sheep sleep is rich in spin-
dles, an EEG feature that is prominent in humans, and has
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been reported in a number of other mammalian species
including rats, mice, cats and monkeys (Andrillon et al.,
2011). Sleep spindles reﬂect coordinated corticothalamic
activity and are correlated with overnight memory consoli-
dation (Tononi and Cirelli, 2014). Interestingly, spindles
are disrupted in many neurological disorders (Wiegand
et al., 1991; Ferrarelli et al., 2007; Rauchs et al., 2008;
Christensen et al., 2014) including Batten disease
(Veneselli et al., 2000). Here, we quantiﬁed sleep spindles
and uncovered trend-level reductions in spindle amplitudes,
but no density change in the Batten disease affected sheep.
It is possible that a change in spindle amplitude is part of
the mechanism underlying learning deﬁcits in Batten
disease.
Although rumination is not directly translational, the
control of chewing is highly relevant, given that dysphagia
is a common symptom in many human neurodegenerative
diseases, including Batten disease, Huntington’s disease,
Alzheimer’s disease and Parkinson’s disease (A˚berg et al.,
2011; Heemskerk and Roos, 2011; Affoo et al., 2013;
Monteiro et al., 2014). The complex and highly temporal
structure of rumination along with its strong dependence
on coordinated motor control (rhythmic chewing, swallow-
ing reﬂex and regurgitation) could make it a valuable read
out for neurological conditions with dysphagia or dysarth-
ria phenotypes. Accordingly, we have found signatures con-
sistent with motor control impairments in CLN5 / Batten
disease affected sheep. The possibility that the observed
differences arose from factors other than motor control,
such as reduced muscle tone, cannot be excluded using
the available data. Nevertheless, rumination warrants fur-
ther investigation as a potential marker of disease progres-
sion. Further investigations will determine if there is a
correlation between decline in rumination efﬁciency and
disease progression.
Our study extends the applicability of sheep for studying
both animal models of neurodegeneration and more gener-
ally, brain function. Sheep should be considered more fre-
quently as a model to bridge the gap between ﬁndings in
rodents and humans, particularly in those cases where the
use of non-human primates is not feasible either due to
ethical, practical or technical reasons. When it comes to
assessing therapeutic avenues that rely on brains of com-
parable size and structure to those of humans, for example
delivering gene therapies or large molecules directly to the
brain, sheep are an especially attractive species. While our
study concentrated on EEG, in vivo electrophysiological
studies could easily be extended to address more reﬁned
questions through the use of high-density recordings of
single neuron activity, targeting speciﬁc cortical and sub-
cortical structures.
The docile nature of sheep, the ease of training in behav-
ioural paradigms (Morton and Avanzo, 2011), along with
their large brains and thick skulls (providing ample oppor-
tunity for ﬁxation of complex implants, e.g. microdrives
and high counts of electrodes), and limited ability or inclin-
ation to interfere with recording equipment, make them an
attractive species to use for in vivo electrophysiological
recordings. With the advent of wireless neural recording
techniques, the opportunities to use sheep to investigate,
for example, spatial navigation in large naturalistic envir-
onments, are increasingly realistic. Although sheep have
been used previously as models for studying brain function,
our study demonstrates how they can be used effectively in
conjunction with modern electrophysiological techniques
thus paving the way for future experiments that are other-
wise not possible in small brained rodents or unfeasible in
non-human primates. Further development of sheep as a
laboratory model has great potential to facilitate brain re-
search in both health and disease.
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